3.68
前日終値:
$3.58
開ける:
$3.55
24時間の取引高:
38,868
Relative Volume:
0.02
時価総額:
$90.33M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.79%
1か月 パフォーマンス:
+2.51%
6か月 パフォーマンス:
+86.80%
1年 パフォーマンス:
-71.07%
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
名前
Artiva Biotherapeutics Inc
セクター
電話
(858) 267-4467
住所
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ARTV
Artiva Biotherapeutics Inc
|
3.68 | 87.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-11 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 開始されました | Jefferies | Buy |
| 2024-08-13 | 開始されました | Needham | Buy |
| 2024-08-13 | 開始されました | TD Cowen | Buy |
| 2024-08-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Artiva Biotherapeutics Inc (ARTV) 最新ニュース
How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser
Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $19.00 - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Artiva Biotherapeutics Inc. stock is seen as undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsWeekly Investment Report & Expert Curated Trade Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosWeekly Market Report & Weekly Consistent Profit Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025 - newser.com
Artiva Biotherapeutics Inc. stock daily chart insights2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
ARTV: Off-the-shelf NK cell therapy for autoimmune disease advances toward pivotal RA trial with strong safety and funding - TradingView
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 By Investing.com - Investing.com UK
Relative strength of Artiva Biotherapeutics Inc. in sector analysisSwing Trade & Free Weekly Watchlist of Top Performers - newser.com
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 - Investing.com India
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Equities Analysts Offer Predictions for ARTV FY2025 Earnings - Defense World
Why Artiva Biotherapeutics Inc. stock is popular among millennialsPortfolio Update Summary & Real-Time Volume Analysis - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Quarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Can Artiva Biotherapeutics Inc. stock resist sector downturnsQuarterly Earnings Summary & Verified Swing Trading Watchlist - newser.com
What risks investors should watch in Artiva Biotherapeutics Inc. stock2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Published on: 2025-11-14 18:41:04 - newser.com
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
HC Wainwright Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) Stock - Defense World
Identifying reversal signals in Artiva Biotherapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - TipRanks
HC Wainwright & Co. Maintains Artiva Biotherapeutics (ARTV) Buy Recommendation - Nasdaq
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases - TipRanks
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge - TipRanks
Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results - TipRanks
Artiva Biotherapeutics Inc (ARTV) 財務データ
Artiva Biotherapeutics Inc (ARTV) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):